Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Avagard 9232 Antiseptic Hand & Body Wash with chlorhexidine gluconate 2%w/w Chlorhexidine gluconate 2%w/w Topical solution 3M New Zealand Limited Pax Australia Pty Limited, Ingleburn, Australia
|
Product:
Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Avagard 9241 Antiseptic Surgical Hand Scrub with chlorhexidine gluconate 4%w/w Chlorhexidine gluconate 4%w/w Topical solution 3M New Zealand Limited Pax Australia Pty Limited, Ingleburn, Australia
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Avagard Antiseptic Hand Lotion Ethanol absolute 61%w/w Ethanol 66.5%w/w equivalent to 61%w/w (absolute) Lotion 3M New Zealand Limited Accupac Inc, Pennsylvania, United States of America
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Meropenem-AFT Meropenem trihydrate 570mg equivalent to Meropenem 500mg Powder for injection AFT Pharmaceuticals Limited Biolab Co Limited, Muang, Thailand
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Meropenem-AFT Meropenem trihydrate 1140mg equivalent to Meropenem 1000mg Powder for injection AFT Pharmaceuticals Limited Biolab Co Limited, Muang, Thailand
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Saxenda Liraglutide 6mg/mL Solution for injection Novo Nordisk Pharmaceuticals Limited Novo Nordisk A/S, Copenhagen, Denmark
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Women’s Regaine Minoxidil 5%w/w Foam Johnson & Johnson (New Zealand) Limited ASM Aerosol-Service AG, Mohlin, Switzerland
|
Dated this 4th day of March 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).